Stockreport

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain? [Yahoo! Finance]

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+) metastatic breast cancer. The research-use-only assay, which includes a qPCR detection ki [Read more]